Published in
American Society for Microbiology, Microbiology Spectrum, 2(10), 2022
DOI: 10.1128/spectrum.02702-21
Links
Tools
Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273
Journal article published in 2022 by
Brian Grunau 
,
Liam Golding,
Martin A. Prusinkiewicz,
Michael Asamoah-Boaheng ,
Richard Armour,
Ana Citlali Marquez,
Agatha N. Jassem,
Vilte Barakauskas,
Sheila F. O’Brien ,
Steven J. Drews ,
Scott Haig,
Pascal M. Lavoie,
David M. Goldfarb
,
Liam Golding,
Martin A. Prusinkiewicz,
Michael Asamoah-Boaheng ,
Richard Armour,
Ana Citlali Marquez,
Agatha N. Jassem,
Vilte Barakauskas,
Sheila F. O’Brien ,
Steven J. Drews ,
Scott Haig,
Pascal M. Lavoie,
David M. Goldfarb
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
The BNT162b2 and mRNA-1273 mRNA SARS-CoV-2 vaccines have demonstrated high efficacy for preventing short-term COVID-19. However, comparative long-term effectiveness is unclear, especially pertaining to the Delta variant.